Suchergebnisse - "Jonas, Jost B."

PubPharm (8)

1

RETINAL VEIN OCCLUSIONS, FROM BASICS TO THE LATEST TREATMENT

enthalten in: Retina (Philadelphia, Pa.) | 2016

von Ho, M. | Liu, D. | Lam, D. | +1

CommentIn: Retina. 2016 Nov;36(11):e112-e113. - PMID 27776020

2

Meta-analysis of the effect of intravitreal bevacizumab versus intravitreal triamcinolone acetonide in central retinal vein occlusion

enthalten in: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics | 2013

von Jin, Z. | Zhu, D. | Tao, Y. | +2

3

Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration

enthalten in: Acta ophthalmologica | 2010

von Jonas, J. | Libondi, T. | Golubkina, L. | +3

4

Intravitreal bevacizumab combined with intravitreal triamcinolone for therapy-resistant exudative age-related macular degeneration

enthalten in: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics | 2010

von Tao, Y. | Jonas, J.

5

Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions

enthalten in: Acta ophthalmologica | 2010

von Jonas, J. | Libondi, T. | Schlichtenbrede, F. | +1

6

Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide

enthalten in: Acta ophthalmologica | 2010

von Rensch, F. | Spandau, U. | Wickenhäuser, A. | +1

7

Toxicity assessment of intravitreal triamcinolone and bevacizumab in a retinal explant mouse model using two-photon microscopy

enthalten in: Investigative ophthalmology & visual science | 2009

von Schlichtenbrede, F. | Mittmann, W. | Rensch, F. | +3

8

Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration

enthalten in: Ophthalmic research | 2009

von Jonas, J. | Ihloff, A. | Harder, B. | +5

1
[1]